Hyperthermia in combined treatment of cancer

Lancet Oncology

Volumn 3, Issue 8, 2002, Pages 487-497

  Wust, P ^a,b   Hildebrandt, B ^b   Sreenivasa, G ^a   Rau, B ^b   Gellermann, J ^a   Riess, H ^b   Felix, R ^a   Schlag, Pm ^b  

^a Department of Radiation Oncology ^*  (United Kingdom)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CANCER VACCINE; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; IFOSFAMIDE; OXALIPLATIN;

ANTENNA; BODY REGIONS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CANCER THERAPY; CONTROLLED STUDY; ELECTRIC FIELD; GENE THERAPY; GLIOBLASTOMA; HEAD AND NECK CANCER; HUMAN; HYPERTHERMIC THERAPY; IN VIVO STUDY; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MELANOMA; MODEL; MOLECULAR MECHANICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RECTUM CANCER; REVIEW; SENSOR; TECHNOLOGY; TEMPERATURE; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA;

EID: 0036339812     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(02)00818-5     Document Type: Review

References (70)

1. Arrhenius relationships from the molecule and cell to the clinic
2. Will hyperthermia conquer the elusive hypoxic cell?
3. An update on the anticancer effects of a combination of chemotherapy and hyperthermia
4. Interaction of hyperthermia and chemotherapy
5. Time-temperature relationship in hyperthermic treatment of malignant and normal tissue in vivo
6. For the clinical application of thermochemotherapy given at mild temperatures
7. Effect of heat on induction and repair of DNA strand breaks in X-irradiated CHO cells
8. Nuclear matrix as a target for hyperthermic killing of cancer cells
9. Heat shock proteins, thermotolerance, and their relevance for clinical hyperthermia
10. Hyperthermia for treatment of rectal cancer: Evaluation for induction of multidrug resistance (mdr1) expression
11. A mechanism for the specific immunogenecity of heat-shock protein.chaperoned peptides
12. Apoptosis in tumors and normal tissues induced by whole body hyperthermia in rats
13. Matched-pair analysis of response to local hyperthermia and megavoltage electron therapy for superficial human tumors
14. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial
15. Preoperative radiochemotherapy in locally advanced or recurrent rectal cancer: Regional radiofrequency hyperthermia correlates with clinical parameters
16. Tumour oxygenation is increased by hyperthermia at mild temperatures
17. Blood flow, oxygen and nutrient supply, and microenvironment of human tumors: A review
18. Influence of elevated temperature on natural killer cell activity, lymphokine-activated killer cell activity and lectin-dependent cytotoxicity of human umbilical cord blood and adult blood cells
19. Heat shock protein 72 on tumor cells: A recognition structure for natural killer cells
20. Cytokine induction by 41.8°C whole body hyperthermia
21. Temperature data and specific absorption rates in pelvic tumors: Predictive factors and correlations
22. Quality assurance guidelines for ESHO protocols
23. Dose uniformity in MECS interstitial hyperthermia: The impact of longitudinal control in model anatomies
24. Clinical evaluation and verification of the hyperthermia treatment planning system HyperPlan
25. Electromagnetic phased arrays for regional hyperthermia: Optimal frequency and antenna arrangement
26. Antenna arrays in the SIGMA-Eye applicator: Interactions and transforming networks
27. Magnetic resonance thermometry during hyperthermia for human high-grade sarcoma
28. MRT-gesteuerte regionale Tiefenhyperthermie
29. Fast 3D monitoring of small temperature changes for hyperthermia using magnetic resonance
30. Modeling and observation of temperature changes in vivo using MRI
31. Whole-body hyperthermia: A secure procedure for patients with various malignancies?
32. Immunological and physiological responses to whole body hyperthermia
33. A nontoxic system for 41,8°C whole body hyperthermia: Results of a phase I study using a radiant heat device
34. Whole-body hyperthermia with water-filtered infrared radiation: Technical-physical aspects and clinical experiences
35. Feasibility and analysis of thermal parameters for the whole body hyperthermia system IRATHERM-2000
36. Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion
37. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas
38. Head and neck cancers: Results of thermoradiotherapy versus rediotherapy
39. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma
40. Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors: Final report by the Radiation Therapy Oncology Group
41. Report of a long-term follow-up in a randomized trial comparing radiation therapy and radiation plus hyperthermia to metastatic lymph nodes in stage IV head and neck cancer patients
42. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials
43. Thermoradiotherapy of patients with locally advanced carcinoma of the rectum
44. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage III cervical carcinoma
45. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistant human tumors. A prospectively controlled randomized study by the Radiation Therapy Group
46. Survival benefit of hyperthermia in a prospective randomised trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme
47. Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma
48. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: A prospective randomized trial
49. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer: Final results of a randomized controlled study
50. A prospective randomized study of regional extremity perfusion in patients with malignant melanoma
51. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities
52. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: Results of a multicenter randomized phase III trial
53. Combined hyperthermia and irradiation in the treatment of superficial tumors: Results of a prospective randomized trial of hyperthermia fractionation (1/wk vs 2/wk)
54. Thermoradiotherapy in the management of superficial malignant tumors
55. Two or six hyperthermia treatments as an adjunct to radiation therapy yield similar tumor responses: Results of a randomized trial
56. Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: A phase II study
57. index is predictive of response of superficial malignancies to hyperthermia and radiation
58. Rationale for using invasive thermometry for regional hyperthermia of pelvic tumors
59. Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer: A phase II clinical trial
60. Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: Long-term results of a phase II study
61. Phase II-Studie zur präoperativen Radio-Chemo-Thermotherapie beim lokal fortgeschrittenen Rektum-Karzinom
62. Hyperthermia in oncology
63. The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy
64. Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix
65. Regional hyperthermia in rectal cancer
66. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
67. Treatment of primary, recurrent or inadequately resected high-risk-tissue sarcomas (STD) of adults: Results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia
68. Combined external beam irradiation and external regional hyperthermia for locally advanced adenocracinoma of the prostate
69. 2 predicts survival in advanced cancer of the uterine cervix
70. Whole body hyperthermia cytokine induction: A review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy